星星
发表于 2025-3-25 04:28:24
Fabio Alves,Arlene Koglin,Bartolomé Mesa-Lao,Mercedes García Martínez,Norma B. de Lima Fonseca,Arthuar (hyaline) cartilage covers the ends of the bones of synovial joints and is a complex, multilayered structure varying in composition with location in a joint, and in relation to load and shear forces at that specific site. When damaged, articular cartilage tissue does not have the ability to repai
机制
发表于 2025-3-25 08:58:47
http://reply.papertrans.cn/67/6651/665093/665093_22.png
tattle
发表于 2025-3-25 15:07:34
http://reply.papertrans.cn/67/6651/665093/665093_23.png
Proclaim
发表于 2025-3-25 15:57:32
http://reply.papertrans.cn/67/6651/665093/665093_24.png
frugal
发表于 2025-3-25 20:02:33
http://reply.papertrans.cn/67/6651/665093/665093_25.png
figure
发表于 2025-3-26 03:35:10
Samuel Läubli,Ulrich Germannside-effects and increase the probability of secondary neoplasms. Clinical benefit from therapy has reached a plateau and local recurrence is still a major problem. Altering the traditionally held view of sarcomagenesis as a purely genetic disease to accommodate the more recent cancer stem cell para
Affiliation
发表于 2025-3-26 06:32:47
Moritz Schaeffer,Barbara Dragsted,Kristian Tangsgaard Hvelplund,Laura Winther Balling,Michael Carlarian cancer is in its heterogeneity, different subtypes and drug resistance. Moreover, the different types of ovarian cancer, such as endometrioid, serous, clear cell and mucinous appends to the complexity of this cancer. These tumors contain a small population of cells known as cancer stem cells (
Expiration
发表于 2025-3-26 08:38:33
http://reply.papertrans.cn/67/6651/665093/665093_28.png
Heart-Rate
发表于 2025-3-26 15:45:09
http://reply.papertrans.cn/67/6651/665093/665093_29.png
粗鲁的人
发表于 2025-3-26 18:28:35
Bergljot Behrensmune response or imposing a state of immunological tolerance. As such, DCs serve as an obvious point of intervention for therapeutic purposes: while targeting DCs to enhance the response to tumour associated antigens (TAAs) remains the goal of cancer immunotherapy, reducing deleterious immune respon